Latest Dividends And Share Buybacks News

DPM Metals delivered record third quarter financial results driven by strong free cash flow and adjusted net earnings, while its recent acquisition of Adriatic Metals' Vareš operation promises higher-than-expected production in 2026.

Dyno Nobel reported a modest revenue dip but a solid 5.6% rise in net profit excluding one-off items for FY25, completing key divestments and advancing its transformation program.

Clime Capital reports an unaudited pre-tax NTA of 78.55 cents per share and announces a December quarter dividend guidance of 1.35 cents, maintaining an active share buyback program.

Ramelius Resources unveils a fully funded five-year growth plan targeting over 500,000 ounces of gold production annually by FY30, backed by major plant upgrades and strong free cash flow projections.

Sequoia Financial Group reported a robust FY25 with a 13.7% rise in EBITDA and a 44% jump in funds under advice, underpinned by strategic restructuring and technology investments.

Katana Capital Limited reported a solid increase in net profit for FY2025 alongside a fully franked dividend and a strategic share buyback, signaling confidence despite lower revenue.

Australian Clinical Labs delivered solid FY25 financial results with revenue up 6.4% and EBIT rising 8.7%, underpinned by operational efficiencies and strategic innovation. The company’s FY26 guidance signals continued growth amid evolving market conditions and government fee pressures.

Australian Clinical Labs reported robust FY25 financial results with revenue and earnings growth, alongside a strong dividend payout and positive outlook for FY26.

GTN Limited reported a modest revenue decline and a sharper EBITDA drop in FY25 but rewarded shareholders with strong returns including dividends, buybacks, and a significant capital return.

WAM Income Maximiser Limited has reported a profitable first half since its April 2025 IPO, declaring its inaugural fully franked monthly dividend and setting guidance for dividend growth. The company’s diversified portfolio of ASX300 equities and investment grade corporate debt has delivered promising returns, underpinning its income and capital growth objectives.

Reliance Worldwide Corporation reports a solid 5.5% sales increase and a 13.5% rise in net profit for FY25, boosted by the Holman acquisition, while cautioning on tariff impacts ahead.

Cochlear Limited reported a 4% revenue rise in FY25, driven by strong implant sales and launched the world’s first smart cochlear implant system. The company forecasts up to 17% profit growth in FY26, underpinned by innovation and expanding markets.